Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentle craniosacral therapy tested to ease breast cancer After-Effects

NCT ID NCT04319510

Symptom relief Sponsor: Universität Duisburg-Essen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether craniosacral therapy, a gentle hands-on technique, can improve quality of life in women who have finished breast cancer treatment. 102 survivors with reduced well-being are randomly assigned to one-on-one therapy, group self-help training, or a waiting list. Researchers measure changes in cancer-related quality of life after 12 and 26 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
craniosacral therapy (a gentle hands-on technique)
What this could lead to
If it works, this could offer a safe, drug-free way to help breast cancer survivors feel better and improve their daily quality of life.
What could go wrong
This is a small, early-stage trial with no blinding, so results may be influenced by placebo effects. The therapy is complementary and not a treatment for cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

102 people

The number who actually took part.

Started

Sep 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Breast cancer (stage I-III) survivors after finishing curative chemotherapy and/or radiation * Impaired breast caner-related quality of life (\< 112,8 points on the FACT-B) Exclusion Criteria: * Planned surgery, adjuvant therapy (chemotherapy and/or radtiation), or rehabilitation during the study period * Pregnancy * Simultaneous participation in other clinical trials

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Complementary therapies

Contacts and locations

Locations

  • Breast Unit, Evang. Kliniken Essen-Mitte

    Essen, 45276, Germany

  • Center for Integrative Medicine and Planetary Health, University Hospital Essen, University of Duisburg-Essen

    Essen, 45130, Germany

  • Department of Gynecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen

    Essen, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.